Cirugía y Radiología y Medicina Física
Departamento
Universidad Europea de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Universidad Europea de Madrid (18)
2024
-
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2023
-
Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial
European urology oncology, Vol. 6, Núm. 1, pp. 58-66
-
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838
2022
-
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study
World Journal of Urology, Vol. 40, Núm. 10, pp. 2459-2466
-
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
Radiotherapy and Oncology, Vol. 172, pp. 1-9
-
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Radiotherapy and Oncology, Vol. 176, pp. 199-207
2021
-
Adjuvant versus early salvage radiotherapy for prostate cancer patients: Time to move on
Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 6, pp. 351-356
-
Clinical implications of (Pro)renin receptor (prr) expression in renal tumours
Diagnostics, Vol. 11, Núm. 2
-
Extreme hypofractionation with sbrt in localized prostate cancer
Current Oncology, Vol. 28, Núm. 4, pp. 2933-2949
-
Management of cholelithiasis in times of COVID-19: A challenge for the system
Cirugia Espanola
-
Reply to editor letter
Cirugia Espanola
-
Salvage local treatment for localized radio-recurrent prostate cancer: A narrative review and future perspectives
Future Oncology, Vol. 17, Núm. 31, pp. 4207-4219
-
Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma
Cancers, Vol. 13, Núm. 4, pp. 1-17
-
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
European Urology Focus
2020
-
Clinical applications of molecular biomarkers in prostate cancer
Cancers, Vol. 12, Núm. 6, pp. 1-25
2019
2018
-
Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 302-314
-
Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain
Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1484-1491